The pilot program in West Virginia successfully covered obesity drugs for state employees, leading to significant health improvements. Patient demand surged as results spread.
The end of funding for obesity medications left many patients rationing their supplies and facing a return of food cravings, reminding us of the drugs' crucial impact.
As the program ended, desperation among patients grew, with individuals resorting to sharing medications and considering copycat versions due to the high costs.
West Virginia’s experience showcases the broader challenge of balancing the high costs of effective obesity treatments with the pressing health needs of patients.
Collection
[
|
...
]